PT854364E - Diagnostico de doencas neurodegenerativas - Google Patents

Diagnostico de doencas neurodegenerativas

Info

Publication number
PT854364E
PT854364E PT98300342T PT98300342T PT854364E PT 854364 E PT854364 E PT 854364E PT 98300342 T PT98300342 T PT 98300342T PT 98300342 T PT98300342 T PT 98300342T PT 854364 E PT854364 E PT 854364E
Authority
PT
Portugal
Prior art keywords
diagnosis
neurodegenerative diseases
neuro
sample
particulate material
Prior art date
Application number
PT98300342T
Other languages
English (en)
Inventor
Harash Kumar Narang
Original Assignee
Biotec Global Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Global Ltd filed Critical Biotec Global Ltd
Publication of PT854364E publication Critical patent/PT854364E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PT98300342T 1997-01-18 1998-01-19 Diagnostico de doencas neurodegenerativas PT854364E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701045.8A GB9701045D0 (en) 1997-01-18 1997-01-18 Diagnosis of neuro-degenerative disorders

Publications (1)

Publication Number Publication Date
PT854364E true PT854364E (pt) 2003-01-31

Family

ID=10806230

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98300342T PT854364E (pt) 1997-01-18 1998-01-19 Diagnostico de doencas neurodegenerativas

Country Status (7)

Country Link
EP (1) EP0854364B1 (pt)
AT (1) ATE223056T1 (pt)
DE (1) DE69807363T2 (pt)
DK (1) DK0854364T3 (pt)
ES (1) ES2185111T3 (pt)
GB (1) GB9701045D0 (pt)
PT (1) PT854364E (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001987B1 (en) 1997-08-01 2010-12-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
WO1999006838A2 (en) * 1997-08-01 1999-02-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel method of detecting amyloid-like fibrils or protein aggregates
WO1999040439A1 (en) * 1998-02-06 1999-08-12 Harash Kumar Narang Diagnosis of neuro-degenerative disorders
US7595199B1 (en) 1998-07-31 2009-09-29 Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. Method of detecting amyloid-like fibrils or protein aggregates
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
DE10061200A1 (de) * 2000-12-08 2002-06-27 Niels Wedemeyer Verfahren und Kit zur Diagnose spongiformer Encephalopathien
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
JPH0327349A (ja) * 1989-06-24 1991-02-05 Asahi Optical Co Ltd 蛋白質、ペプチド及びアミノ酸の分離方法
EP0600951A4 (en) * 1991-08-01 1996-10-30 Paul H Voorheis Diagnostic method for alzheimer's disease.
GB9117910D0 (en) * 1991-08-20 1991-10-09 Nat Res Dev Oligonucleotides and their use in an assay
HUT77339A (hu) * 1994-11-29 1998-03-30 The Minister Of Agriculture, Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Eljárás szivacsszerű agybetegség kimutatására
HUT77340A (hu) * 1994-11-29 1998-03-30 The Minister Of Agriculture, Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Eljárás szivacsszerű agybetegség kimutatására

Also Published As

Publication number Publication date
ES2185111T3 (es) 2003-04-16
DE69807363D1 (de) 2002-10-02
GB9701045D0 (en) 1997-03-05
DE69807363T2 (de) 2003-04-30
DK0854364T3 (da) 2002-12-23
ATE223056T1 (de) 2002-09-15
EP0854364B1 (en) 2002-08-28
EP0854364A1 (en) 1998-07-22

Similar Documents

Publication Publication Date Title
ES2061873T3 (es) Enriquecimiento y concentracion de proteinas por ultrafiltracion.
DE3685344D1 (de) Vorrichtung zur feststellung von okkultem blut.
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
DE3781992D1 (de) Vorrichtung zum erkennen von hindernissen fuer kraftfahrzeuge.
FR2554623B1 (fr) Procede d'analyse de la parole independant du locuteur
ATE366812T1 (de) Neue methode zur erkennung eines stoffes, der die interaktion zwischen einem tnf-liganden und seinem rezeptor auf b-zellen moduliert
ES2163025T3 (es) Sistema y metodo para la modificacion y la purificacion de peptidos.
DE3765138D1 (de) Mehrschichtiges element zur quantitativen analyse von immunoreagenzien.
DE59101912D1 (de) Vorrichtung zur Analyse von Druckkontrollfeldern.
ATE271603T1 (de) Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden
PT854364E (pt) Diagnostico de doencas neurodegenerativas
DE3769808D1 (de) Vorrichtung zur ueberwachung von okkultem blut.
DE69637406D1 (de) Vorrichtung zum Überwachen von sich bewegenden Körpern
DE69805854D1 (de) Vorrichtung für ein handhabungsfahrzeug
PT1105508E (pt) Metodo de purificacao de complexos de biomoleculas ou de proteinas
NO903681D0 (no) Monoklonale antistoffer mot aktiverte ras-proteiner med aminosyremutasjoner i posisjon 13 i proteinet.
ATE22651T1 (de) Verfahren zum reinigen bzw. anreichern von biologisch aktiven proteinen und hierzu geeignetes mittel.
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
CA2286279A1 (en) Diagnosis of neuro-degenerative disorders
ES2097158T3 (es) Ensayo funcional para la determinacion de la actividad de proteina s.
FR2591339B1 (fr) Procede pour mesurer l'interaction dans la zone paroi-fluide, notamment de l'ecoulement sanguin dans les vaisseaux
ATE60445T1 (de) Verfahren und testelement zum auffinden von zellaesionen.
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
ATE312914T1 (de) Rdgb-proteine
BR9816079A (pt) Diagnóstico de desordens neuro-degenerativas